Next Article in Journal
Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
Next Article in Special Issue
Lipophilic Toxin Profile in Mytilus galloprovincialis during Episodes of Diarrhetic Shellfish Poisoning (DSP) in the N.E. Adriatic Sea in 2006
Previous Article in Journal
Casbane Diterpene as a Promising Natural Antimicrobial Agent against Biofilm-Associated Infections
Previous Article in Special Issue
µ-Conotoxins as Leads in the Development of New Analgesics
Article Menu

Export Article

Open AccessReview
Molecules 2011, 16(1), 202-220;

Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication

Microbiotix, Inc., One Innovation Drive, Worcester, MA 01605, USA
Target, Structure-Based Drug Discovery Group, SAIC-Frederick, Inc., National Cancer Institute at Frederick, 1050 Boyles Street, Frederick, MD 21702, USA
Author to whom correspondence should be addressed.
Received: 30 November 2010 / Revised: 20 December 2010 / Accepted: 29 December 2010 / Published: 30 December 2010
(This article belongs to the Special Issue Toxins - Organic and Analytical Chemistry)
Full-Text   |   PDF [3737 KB, uploaded 18 June 2014]   |  


Botulinum neurotoxins (BoNTs) are the most potent of known toxins and are listed as category A biothreat agents by the U.S. CDC. The BoNT-mediated proteolysis of SNARE proteins inhibits the exocytosis of acetylcholine into neuromuscular junctions, leading to life-threatening flaccid paralysis. Currently, the only therapy for BoNT intoxication (which results in the disease state botulism) includes experimental preventative antibodies and long-term supportive care. Therefore, there is an urgent need to identify and develop inhibitors that will serve as both prophylactic agents and post-exposure ‘rescue’ therapeutics. This review focuses on recent progress to discover and develop small molecule inhibitors as therapeutic countermeasures for BoNT intoxication. View Full-Text
Keywords: inum neurotoxin; inhibitor; drug discovery inum neurotoxin; inhibitor; drug discovery

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Li, B.; Peet, N.P.; Butler, M.M.; Burnett, J.C.; Moir, D.T.; Bowlin, T.L. Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication. Molecules 2011, 16, 202-220.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top